Rachna Khosla - Net Worth and Insider Trading
Rachna Khosla Net Worth
The estimated net worth of Rachna Khosla is at least $2 Million dollars as of 2023-09-30. Rachna Khosla is the SVP, Business Development of Amgen Inc and owns about 6,630 shares of Amgen Inc (AMGN) stock worth over $2 Million. Details can be seen in Rachna Khosla's Latest Holdings Summary section.
Transaction Summary of Rachna Khosla
Rachna Khosla Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rachna Khosla owns 1 companies in total, including Amgen Inc (AMGN) .
Rachna Khosla Latest Holdings Summary
Rachna Khosla currently owns a total of 1 stock. Rachna Khosla owns 6,630 shares of Amgen Inc (AMGN) as of November 9, 2022, with a value of $2 Million.
Rachna Khosla Form 4 Trading Tracker
According to the SEC Form 4 filings, Rachna Khosla has made a total of 1 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amgen Inc is the sale of 387 shares on November 9, 2022, which brought Rachna Khosla around $113,352.
Insider Trading History of Rachna Khosla
Rachna Khosla Trading Performance
Rachna Khosla Ownership Network
Ownership Network List of Rachna Khosla
Ownership Network Relation of Rachna Khosla
Rachna Khosla Owned Company Details
What does Amgen Inc do?
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amjevita (biosimilar Humira).
Who are the key executives at Amgen Inc?
Rachna Khosla is the SVP & Business Development of Amgen Inc. Other key executives at Amgen Inc include VP & Finance & CAO Matthew C. Busch , SVP & Human Resources Derek Miller , and VP & Finance & CAO Linda H. Louie .
Amgen Inc (AMGN) Insider Trades Summary
Over the past 18 months, Rachna Khosla made 1 insider transaction in Amgen Inc (AMGN) with a net sale of 387. Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 800 shares made by R Sanders Williams , a net sale of 13,500 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .
In summary, during the past 3 months, insiders sold 9,558 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 9,558 shares. During the past 18 months, 31,390 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 31,390 shares.
Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amgen Inc Insider Transactions
Rachna Khosla Mailing Address
Above is the net worth, insider trading, and ownership report for Rachna Khosla. You might contact Rachna Khosla via mailing address: One Amgen Center Drive, Thousand Oaks Ca 91320.